172 related articles for article (PubMed ID: 28455724)
21. Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer.
Fujita K; Hayashi T; Matsuzaki K; Nakata W; Masuda M; Kawashima A; Ujike T; Nagahara A; Tsuchiya M; Kobayashi Y; Nojima S; Uemura M; Morii E; Miyoshi E; Nonomura N
Oncotarget; 2016 Aug; 7(35):56643-56649. PubMed ID: 27494861
[TBL] [Abstract][Full Text] [Related]
22. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers.
Nakano M; Nakagawa T; Ito T; Kitada T; Hijioka T; Kasahara A; Tajiri M; Wada Y; Taniguchi N; Miyoshi E
Int J Cancer; 2008 May; 122(10):2301-9. PubMed ID: 18214858
[TBL] [Abstract][Full Text] [Related]
23. Multiplex detection of pancreatic cancer biomarkers using a SERS-based immunoassay.
Banaei N; Foley A; Houghton JM; Sun Y; Kim B
Nanotechnology; 2017 Nov; 28(45):455101. PubMed ID: 28937361
[TBL] [Abstract][Full Text] [Related]
24. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
25. Target-selective photo-degradation of AFP-L3 and selective photo-cytotoxicity against HuH-7 hepatocarcinoma cells using an anthraquinone-PhoSL hybrid.
Okuyama M; Ueno H; Kobayashi Y; Kawagishi H; Takahashi D; Toshima K
Chem Commun (Camb); 2016 Feb; 52(10):2169-72. PubMed ID: 26698630
[TBL] [Abstract][Full Text] [Related]
26. Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer.
Lin Z; Simeone DM; Anderson MA; Brand RE; Xie X; Shedden KA; Ruffin MT; Lubman DM
J Proteome Res; 2011 May; 10(5):2602-11. PubMed ID: 21417406
[TBL] [Abstract][Full Text] [Related]
27. Identification of the epitope of 10-7G glycan antibody to recognize cancer-associated haptoglobin.
Morishita K; Maki Y; Takamatsu S; Ito N; Koda S; Motooka K; Kamada Y; Kajihara Y; Miyoshi E
Anal Biochem; 2020 Mar; 593():113588. PubMed ID: 31981485
[TBL] [Abstract][Full Text] [Related]
28. Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells.
Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Nakagawa T; Matsumoto H; Asahi M; Koyama N; Miyoshi E
Biochem Biophys Res Commun; 2008 Dec; 377(3):792-6. PubMed ID: 18951869
[TBL] [Abstract][Full Text] [Related]
29. Aided Diagnosis of Hepatocellular Carcinoma Using Serum Fucosylated Haptoglobin Ratios.
Shang S; Li W; Qin X; Zhang S; Liu Y
J Cancer; 2017; 8(5):887-893. PubMed ID: 28382152
[TBL] [Abstract][Full Text] [Related]
30. Identification of fucosylated haptoglobin-producing cells in pancreatic cancer tissue and its molecular mechanism.
Ito N; Yamada M; Morishita K; Nojima S; Motooka K; Sakata N; Asuka T; Otsu R; Takamatsu S; Kamada Y; Mori S; Akita H; Eguchi H; Morii E; Miyoshi E
Glycoconj J; 2021 Feb; 38(1):45-54. PubMed ID: 33523362
[TBL] [Abstract][Full Text] [Related]
31. Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.
Okano T; Seike M; Kuribayashi H; Soeno C; Ishii T; Kida K; Gemma A
Int J Oncol; 2016 Mar; 48(3):945-52. PubMed ID: 26783151
[TBL] [Abstract][Full Text] [Related]
32. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
[TBL] [Abstract][Full Text] [Related]
33. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues.
McDowell CT; Klamer Z; Hall J; West CA; Wisniewski L; Powers TW; Angel PM; Mehta AS; Lewin DN; Haab BB; Drake RR
Mol Cell Proteomics; 2021; 20():100012. PubMed ID: 33581409
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9.
Ritchie SA; Chitou B; Zheng Q; Jayasinghe D; Jin W; Mochizuki A; Goodenowe DB
World J Gastroenterol; 2015 Jun; 21(21):6604-12. PubMed ID: 26074698
[TBL] [Abstract][Full Text] [Related]
35. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development.
Asazawa H; Kamada Y; Takeda Y; Takamatsu S; Shinzaki S; Kim Y; Nezu R; Kuzushita N; Mita E; Kato M; Miyoshi E
Clin Chem Lab Med; 2015 Jan; 53(1):95-102. PubMed ID: 25060348
[TBL] [Abstract][Full Text] [Related]
36. Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer.
Dowling P; Clarke C; Hennessy K; Torralbo-Lopez B; Ballot J; Crown J; Kiernan I; O'Byrne KJ; Kennedy MJ; Lynch V; Clynes M
Int J Cancer; 2012 Aug; 131(4):911-23. PubMed ID: 21953030
[TBL] [Abstract][Full Text] [Related]
37. Serum fucosylated haptoglobin as a novel prognostic biomarker predicting high-Gleason prostate cancer.
Fujita K; Shimomura M; Uemura M; Nakata W; Sato M; Nagahara A; Nakai Y; Takamatsu S; Miyoshi E; Nonomura N
Prostate; 2014 Jul; 74(10):1052-8. PubMed ID: 24802742
[TBL] [Abstract][Full Text] [Related]
38. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation.
Okuyama N; Ide Y; Nakano M; Nakagawa T; Yamanaka K; Moriwaki K; Murata K; Ohigashi H; Yokoyama S; Eguchi H; Ishikawa O; Ito T; Kato M; Kasahara A; Kawano S; Gu J; Taniguchi N; Miyoshi E
Int J Cancer; 2006 Jun; 118(11):2803-8. PubMed ID: 16385567
[TBL] [Abstract][Full Text] [Related]
39. α1-3/4 fucosylation at Asn 241 of β-haptoglobin is a novel marker for colon cancer: a combinatorial approach for development of glycan biomarkers.
Park SY; Lee SH; Kawasaki N; Itoh S; Kang K; Hee Ryu S; Hashii N; Kim JM; Kim JY; Hoe Kim J
Int J Cancer; 2012 May; 130(10):2366-76. PubMed ID: 21780104
[TBL] [Abstract][Full Text] [Related]
40. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
